LOGIN  |  REGISTER

Recent Insider Transactions - ARS Pharmaceuticals (NASDAQ: SPRY)

Follow NASDAQ:SPRY Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/17/2024
Sell
$11.67
50,000
$584K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/17/2024
Sell
$11.67
50,000
$584K
1.10M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/17/2024
Sell
$11.67
50,000
$584K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/17/2024
Sell
$11.67
50,000
$584K
1.10M
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/12/2024
Buy
$0.84
117,333
$99K
253,713
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/13/2024
Buy
$1.44
27,272
$39K
163,652
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/12/2024
Sell
$12.27
117,333
$1.439M
136,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/13/2024
Sell
$12.06
27,272
$329K
136,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/12/2024
Sell
$0.84
117,333
$99K
119,047
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/13/2024
Sell
$1.44
27,272
$39K
55,461
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
12/11/2024
Sell
$0.64
15,000
$10K
46,828
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
12/12/2024
Buy
$0.64
25,000
$16K
31,024
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
12/12/2024
Sell
$0.64
25,000
$16K
21,828
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
12/11/2024
Buy
$0.64
15,000
$10K
21,024
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
12/12/2024
Sell
$12.30
25,000
$307K
6,024
NASDAQ SPRY ARS Pharmaceuticals
Dorsey Brian / officer: Chief Operating Officer
12/11/2024
Sell
$12.43
15,000
$186K
6,024
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/10/2024
Buy
$0.84
50,000
$42K
186,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/10/2024
Sell
$13.15
50,000
$658K
136,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/10/2024
Sell
$0.84
50,000
$42K
0
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/10/2024
Sell
$13.17
50,000
$658K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/10/2024
Sell
$13.16
50,000
$658K
1.15M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/10/2024
Sell
$13.17
50,000
$658K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/10/2024
Sell
$13.16
50,000
$658K
1.15M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/06/2024
Buy
$8.42
11,876
$100K
4.33M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/06/2024
Buy
$8.42
11,876
$100K
3.43M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/06/2024
Buy
$1.44
13,789
$20K
3.42M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/06/2024
Sell
$8.42
11,876
$100K
1.09M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/06/2024
Sell
$8.42
11,876
$100K
338,124
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
12/06/2024
Sell
$1.44
13,789
$20K
20,684
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/06/2024
Buy
$8.42
11,876
$100K
4.33M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/06/2024
Buy
$8.42
11,876
$100K
3.43M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/06/2024
Buy
$1.44
13,789
$20K
3.42M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/06/2024
Sell
$8.42
11,876
$100K
1.09M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/06/2024
Sell
$8.42
11,876
$100K
338,124
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
12/06/2024
Sell
$1.44
13,789
$20K
20,684
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/06/2024
Buy
$0.84
50,000
$42K
186,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/05/2024
Buy
$0.84
49,640
$42K
186,020
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/04/2024
Buy
$0.84
45,000
$38K
181,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/04/2024
Sell
$0.84
45,000
$38K
149,640
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/05/2024
Sell
$14.13
49,640
$702K
136,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/04/2024
Sell
$13.95
45,000
$628K
136,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/06/2024
Sell
$14.23
50,000
$712K
136,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/05/2024
Sell
$0.84
49,640
$42K
100,000
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/06/2024
Sell
$0.84
50,000
$42K
50,000
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/03/2024
Sell
$0.84
41,740
$35K
194,640
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/03/2024
Buy
$0.84
41,740
$35K
181,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/03/2024
Buy
$0.84
3,260
$3K
139,640
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/03/2024
Sell
$13.19
45,000
$593K
136,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/02/2024
Sell
$13.67
45,000
$615K
136,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/02/2024
Sell
$0.84
45,000
$38K
3,260
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
12/03/2024
Sell
$0.84
3,260
$3K
0
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/02/2024
Buy
$1.27
29,628
$38K
307,590
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/03/2024
Buy
$3.15
62,378
$196K
298,330
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/02/2024
Buy
$1.27
67,616
$86K
277,962
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/03/2024
Buy
$1.27
25,606
$33K
235,952
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/04/2024
Buy
$3.15
14,772
$47K
225,118
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/02/2024
Sell
$13.55
96,343
$1.306M
211,247
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/02/2024
Sell
$14.34
901
$13K
210,346
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/03/2024
Sell
$13.26
87,984
$1.167M
210,346
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/04/2024
Sell
$13.75
14,772
$203K
210,346
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/03/2024
Sell
$3.15
62,378
$196K
73,836
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/04/2024
Sell
$3.15
14,772
$47K
59,064
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/02/2024
Sell
$1.27
29,628
$38K
25,606
NASDAQ SPRY ARS Pharmaceuticals
Shawver Laura / director
12/03/2024
Sell
$1.27
25,606
$33K
0
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
12/02/2024
Sell
$1.50
3,717
$6K
590,871
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
12/04/2024
Sell
$1.50
6,283
$9K
584,588
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
12/04/2024
Buy
$1.50
6,283
$9K
11,976
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
12/02/2024
Buy
$1.50
3,717
$6K
9,410
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
12/02/2024
Sell
$14.11
3,717
$52K
5,693
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
12/04/2024
Sell
$14.00
6,283
$88K
5,693
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
11/25/2024
Sell
$14.00
32,814
$459K
203,566
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
11/26/2024
Sell
$14.05
42,186
$593K
161,380
NASDAQ SPRY ARS Pharmaceuticals
Chakma Justin / officer: Chief Business Officer
11/27/2024
Sell
$14.39
25,000
$360K
136,380
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/19/2024
Sell
$13.95
50,000
$698K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/19/2024
Sell
$13.95
50,000
$697K
1.20M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/19/2024
Sell
$13.95
50,000
$698K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/19/2024
Sell
$13.95
50,000
$697K
1.20M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/12/2024
Sell
$16.76
45,045
$755K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/12/2024
Sell
$17.64
4,955
$87K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/12/2024
Sell
$16.76
45,124
$756K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/12/2024
Sell
$17.64
4,876
$86K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/12/2024
Sell
$16.76
45,045
$755K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/12/2024
Sell
$17.64
4,955
$87K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/12/2024
Sell
$16.76
45,124
$756K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/12/2024
Sell
$17.64
4,876
$86K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/11/2024
Sell
$17.45
40,596
$708K
5.50M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/11/2024
Sell
$17.45
40,596
$708K
5.50M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/11/2024
Sell
$18.15
223,632
$4.059M
5.27M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/11/2024
Sell
$18.15
223,632
$4.059M
5.27M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/12/2024
Sell
$17.16
7,853
$135K
5.27M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/12/2024
Sell
$17.16
7,854
$135K
5.27M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/12/2024
Sell
$17.77
9,554
$170K
5.26M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/12/2024
Sell
$17.77
9,553
$170K
5.26M

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous